同德化工(002360.SZ):與兩公司分別簽署工程爆破合同
格隆匯1月6日丨同德化工(002360.SZ)公佈,公司為進一步擴大公司爆破服務業務規模,提高公司的競爭實力和盈利能力,實現股東利益最大化,在不斷加大工程爆破服務市場開拓力度的基礎上,於近日,公司的全資子公司山西同德爆破工程有限責任公司(“同德爆破”)分別與山西忻州神達樑家磧煤業有限公司和山西煤炭運銷集團貓兒溝煤業有限公司簽署了露天煤礦採、剝工程合同。
公司的全資子公司同德爆破是擁有山西省公安廳核發的一級爆破作業單位許可資質,人才資金技術實力雄厚,完全具備順利履行合同的能力。
上述項目的順利實施有助於公司爆破服務業務規模的擴大和盈利能力的提升,對公司未來的經營業績將產生積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.